# An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World

> **NCT05669794** · — · ACTIVE_NOT_RECRUITING · sponsor: **AbbVie** · enrollment: 300 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05669794
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-21
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05669794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05669794, "An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05669794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*